Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance

Abstract

BackgroundCoronary microvascular dysfunction is highly prevalent in patients with amyloid light-chain (AL) cardiac amyloidosis (AL-CA). The aim of this study was to clarify the feasibility of first-pass perfusion imaging using 3 T cardiovascular magnetic resonance (CMR) for evaluating the difference in left ventricular (LV) regional myocardial microvascular function among normal subjects and in patients with AL-CA. The amyloidosis patients were classified into those with impaired systolic function [LV ejection fraction (LVEF) < 50 %] and those with preserved systolic function.MethodsIn total, 32 patients with biopsy-proven AL-CA, including 11 AL-CA patients with systolic dysfunction, 21 AL-CA patients with preserved systolic function, and 25 healthy subjects, underwent CMR examination. LV regional myocardial perfusion parameters included upslope, time to maximum signal intensity (TTM) and max signal intensity (MaxSI) were compared among the three patient groups. Receiver operating characteristic analysis was performed to determine whether perfusion parameters could be used in discriminating regional myocardial microvascularity between AL-CA patients and normal subjects.ResultsThe patients with AL-CA had significantly reduced first-pass perfusion upslope and MaxSI, and increased TTM compared with the normal subjects (all P < 0.01). Compared with the patients with AL-CA and preserved LVEF, the patients with AL-CA and impaired systolic function had a longer TTM in the basal (47.05 ± 16.59 vs. 39.68 ± 19.11; P = 0.002) and mid-ventricular (44.61 ± 16.34 vs. 37.74 ± 18.25; P = 0.002) segments; lower upslope in the basal (2.41 ± 1.32 vs. 3.60 ± 1.68; P < 0.0001), mid-ventricular (2.82 ± 1.34 vs. 4.15 ± 2.02; P < 0.0001), and apical (3.71 ± 1.38 vs. 4.97 ± 2.55; P = 0.004) segments; and lower MaxSI (31.67 ± 15.23 vs. 37.96 ± 11.15; P < 0.0001) in the basal segment. The ROC curve analysis revealed that the first-pass upslope, TTM, and MaxSI may be used as indicators for differentiating microcirculation between AL-CA patients with preserved or impaired systolic function and normal subjects.ConclusionsThe differences in LV regional myocardial microvascular function among normal subjects, AL-CA patients with systolic dysfunction, and AL-CA patients with preserved systolic function can be monitored using first-pass perfusion CMR.

The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis

“…1,59 T2 data needs multi-centre corroboration and we also need more robust methods of being able to correlate cardiac histology with ECV, T1, and T2 mapping data. Future work includes exploration of resting perfusion abnormalities known to occur in some cases of cardiac amyloidosis 60,61 which are very likely to be important in risk stratification. And conclusive demonstration of amyloid regression coupled with proof that the new eradication therapies are safe and effective could prove a revolutionary combination to help end the scourge of this disease.…”

Ventricular Arrhythmias in Cardiac Amyloidosis: A Review of Current Literature

“… 14 Thirdly, micro- and macro- vascular myocardial ischaemia from amyloid deposition, can be demonstrated by regional myocardial dysfunction as assessed by cardiac MRI. 15 …”

Automated Quantitative Stress Perfusion in a Clinical Routine

“…37 Using CMR, semi-quantitative perfusion has been shown to differentiate amyloidosis from normal patients and to identify patients with normal and lower LV function. 38 In summary, fast, efficient quantitative perfusion for clinical practice and research would have advantages for disease identification and characterization, adding prognostic information and increasing reliability and adding the ability to characterize microvascular disease in CAD and cardiomyopathies, potentially aiding therapeutic drug development and treatment monitoring.…”